Whittier Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Whittier Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.2M	Buy	257,702 +19,767	+8%	+$2.47M	0.37%	63
2025 Q4	$29M	Buy	237,935 +5,311	+2%	+$609K	0.31%	67
2025 Q3	$24.1M	Buy	232,624 +1,855	+0.8%	+$167K	0.27%	72
2025 Q2	$19.1M	Sell	230,769 -96,332	-29%	-$7.69M	0.23%	85
2025 Q1	$26.5M	Buy	327,101 +6,361	+2%	+$569K	0.37%	59
2024 Q4	$28.9M	Buy	320,740 +9,713	+3%	+$941K	0.38%	55
2024 Q3	$30.7M	Buy	311,027 +9,976	+3%	+$980K	0.41%	56
2024 Q2	$27.9M	Buy	301,051 +13,380	+5%	+$1.2M	0.4%	55
2024 Q1	$27.3M	Buy	287,671 +9,372	+3%	+$870K	0.4%	61
2023 Q4	$24.8M	Buy	278,299 +3,387	+1%	+$252K	0.4%	61
2023 Q3	$20.1M	Buy	274,912 +9,232	+3%	+$737K	0.36%	68
2023 Q2	$22.1M	Sell	265,680 -321	-0.1%	-$26.8K	0.38%	65
2023 Q1	$20.3M	Buy	266,001 +8,467	+3%	+$703K	0.37%	70
2022 Q4	$21.4M	Sell	257,534 -7,091	-3%	-$574K	0.42%	58
2022 Q3	$21M	Buy	264,625 +158,110	+148%	+$13.3M	0.44%	55
2022 Q2	$7.91M	Sell	106,515 -166,519	-61%	-$12.5M	0.16%	139
2022 Q1	$24.5M	Sell	273,034 -7,795	-3%	-$720K	0.41%	58
2021 Q4	$31.4M	Buy	280,829 +2,341	+0.8%	+$282K	0.51%	49
2021 Q3	$35M	Buy	278,488 +6,629	+2%	+$854K	0.64%	34
2021 Q2	$36.8M	Buy	271,859 +15,502	+6%	+$2.04M	0.66%	33
2021 Q1	$34.8M	Buy	256,357 +21,072	+9%	+$3.15M	0.68%	34
2020 Q4	$33.1M	Buy	235,285 +11,227	+5%	+$1.44M	0.71%	30
2020 Q3	$25M	Buy	224,058 +7,621	+4%	+$854K	0.59%	38
2020 Q2	$24.2M	Buy	216,437 +2,099	+1%	+$207K	0.67%	34
2020 Q1	$16.6M	Buy	214,338 +7,144	+3%	+$633K	0.54%	50
2019 Q4	$19.7M	Buy	207,194 +5,120	+3%	+$443K	0.52%	49
2019 Q3	$15.4M	Buy	202,074 +1,486	+0.7%	+$123K	0.44%	54
2019 Q2	$17.6M	Buy	200,588 +7,012	+4%	+$598K	0.52%	46
2019 Q1	$17.5M	Buy	193,576 +9,391	+5%	+$799K	0.54%	42
2018 Q4	$13.2M	Buy	184,185 +30,207	+20%	+$2.43M	0.45%	56
2018 Q3	$14.8M	Buy	153,978 +1,560	+1%	+$151K	0.46%	55
2018 Q2	$14.5M	Buy	152,418 +16,029	+12%	+$1.47M	0.48%	52
2018 Q1	$12M	Buy	136,389 +134,464	+6,985%	+$12.3M	0.4%	67
2017 Q4	$163K	Hold	1,925	–	–	0.01%	532
2017 Q3	$167K	Sell	1,925 -2,470	-56%	-$198K	0.01%	525
2017 Q2	$340K	Buy	4,395 +2,470	+128%	+$175K	0.01%	395
2017 Q1	$133K	Hold	1,925	–	–	0.01%	535
2016 Q4	$114K	Hold	1,925	–	–	﹤0.01%	565
2016 Q3	$128K	Hold	1,925	–	–	0.01%	527
2016 Q2	$104K	Buy	+1,925	New	+$105K	﹤0.01%	576

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Whittier Trust's XBI Position: Q1 2026 in Review

Whittier Trust increased its State Street SPDR S&P Biotech ETF (XBI) stake by 8.3% in Q1 2026, buying an estimated $2.47M and bringing the position to 257,702 shares worth $33.2M. The position accounts for 0.37% of the portfolio, ranked #63.

Whittier Trust first reported a position in XBI in Q2 2016 and has held it in 40 quarters since. The position peaked at $36.8M in Q2 2021. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Whittier Trust held 257,702 shares of State Street SPDR S&P Biotech ETF worth $33.2M as of Q1 2026.
Whittier Trust bought 19,767 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $2.47M.
State Street SPDR S&P Biotech ETF made up 0.37% of Whittier Trust's portfolio in Q1 2026, its #63 holding.
Whittier Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 40 quarters since.
Whittier Trust's State Street SPDR S&P Biotech ETF position peaked at $36.8M in Q2 2021.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.